Erika Santos Horta, MD
Full Member
| Research Program:
Cancer Therapeutics
Faculty Rank:
Assistant Research Professor
Campus:
University of Arkansas for Medical Sciences
College:
College of Medicine
Department:
Neurology
|
Cancer Research Interest
- Disease Site Focus: Brain
- Research Focus Area: Treatment, Diagnosis/ Prognosis
- Type of Research: Clinical
- Research Keywords: brain tumors, neurofibromatosis, gliomas, meningiomas, clinical trials
- Research Interest Statement: My mission is to improve the care of patients with brain tumors through developing clinical trials, disseminating knowledge and by listening to my patients experiences.
Contact Information
- Email Address: ESANTOSHORTA@UAMS.EDU
- Profiles Research Networking Software: View Profile
Open Clinical Trials
- “NRG-BN011 A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma” (NCT05095376)
- “A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy” (NCT04762069)
- “CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS) (CLICK-MS)” (NCT03933215)
Active Grants
- Children's Tumor Foundation – CTF-2022-12-002“Adult NF Clinic Program Building Pilot Project”Principal Investigator07/01/22 – 06/30/24
Publications
- Horta E, Burke-Smith C, Megna BW, [et al.]. Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system. Scientific reports. 2022 12(1):18668. PMID: 36333367. PMCID: PMC9636207.
- Horta E, Bongiorno C, Ezzeddine M, Neil EC. Neurotoxicity of antibodies in cancer therapy: A review. Clinical neurology and neurosurgery. 2020 188:105566. PMID: 31731087.